Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunotherapy for Hepatocellular Carcinoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Summary
This study is an observational real-world research conducted on Chinese hepatocellular carcinoma (HCC) patients. Its primary objective is to evaluate the safety and efficacy of immunotherapy-based combination therapies in Chinese HCC patients within the practical context of real-world conditions.
Official title: A Real-world Study of Immunotherapy-based Combination Therapies in Chinese Patients With Hepatocellular Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11000
Start Date
2024-03-01
Completion Date
2026-12-31
Last Updated
2024-04-10
Healthy Volunteers
Not specified
Conditions
Interventions
Immunotherapy-based Combination Therapies
immunotherapy-based combination therapies in Chinese HCC patients within the practical context of real-world conditions
Locations (1)
Jiangsu Province Hospital
Nanjing, Jiangsu, China